LY3113593

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Chronic Kidney DiseaseKidney Failure, Chronic

Phase 1

A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis

CompletedNCT02144285

Eli Lilly and CompanyKidney Failure, Chronic

Start: 2014-06-30End: 2015-08-31Updated: 2019-01-22

A Study of LY3113593 in Participants With Chronic Kidney Disease

CompletedNCT02604160

Eli Lilly and CompanyChronic Kidney Disease

Start: 2015-11-17End: 2016-06-22Updated: 2019-03-21